Carbon Monoxide may Help Protect Vision in Diabetes

An ingested liquid that ultimately delivers a small dose of carbon monoxide to the eye appears to target key factors that damage or destroy vision in both type 1 and 2 diabetes, according to scientists at The Medical College of Georgia. Early evidence shows that HBI-002, a low-dose oral compound developed by Hillhurst Biopharmaceuticals and already in early-stage trials for sickle cell disease, can safely reduce oxidative stress and inflammation in the retina, which occurs in diabetic retinopathy.

Diabetic retinopathy is the most frequent cause of new cases of blindness among those age 20-74, and is strongly related to how long the individual has had diabetes, according to the American Diabetes Association.

“At the right dose, carbon monoxide can impact both Inflammation and oxidative stress”, says Dr. Pamela Martin, cell biologist and biochemist in the MCG Department of Biochemistry and Molecular Biology and Vision Discovery Institute at Augusta University.

Many of our cells and tissues are actively and regularly producing small amounts of colorless, odorless gas, carbon monoxide to protect themselves from the damage of high and/or chronic inflammation and oxidative stress.

The enzyme heme oxygenase 1, a common component of many tissues including oxygen-carrying hemoglobin and immune cells reduces oxidative stress and inflammation, and one of the ways it does that is by releasing small amounts of carbon monoxide.

In fact heme oxygenase 1 is naturally upregulated in our cells in response to increased levels of the destructive states.

Advertisement

When fuel-burning furnaces can cause high levels of carbon monoxide to accumulate, the small, steady production of carbon monoxide from the cell machinery doesn’t accumulate in our bodies.

In new studies, researchers are looking at the impact of the compound in both an acute ischemic model, when the retina suddenly is not getting sufficient oxygen because of oxidative stress followed by its normal companion inflammation, as well as a model of more natural disease progression.

Advertisement

The retina is considered an extension of the brain, is comprised of intricate layers of nerves that line the back part of the eye and sense light, which the brain transforms into images.

cell types in the retina are among the highest metabolically active cell types, which means they naturally generate a lot of oxidative stress, and identifying non-invasive methods to reduce blood pressure in the retina can be useful.

The liquid turns into carbon monoxide’s more familiar gaseous state in the intestines, where it naturally binds to hemoglobin, the oxygen-carrying component of blood, and then travels up to the eye in the blood.

Once in the retina, the small dose of carbon monoxide finds the heme oxygenase enzyme in retinal cells and helps induce the steps that normally yield its desired antioxidant, anti-inflammatory action.

To objectively measure its impact, the scientists have functional tests that like an electrocardiogram of the heart, which indicate how different cells are firing and signaling.

They can also look directly at the retina for telltale signs of damage: Diabetes prompts cell death and a thinning of the retina and can cause retinal detachment.

RNA and protein analysis will give more evidence of whether they are getting the increased expression of good genes and decreased expression of the problematic ones in response to treatment.

Meanwhile, levels of the complex carboxyhemoglobin, which forms inside red blood cells when hemoglobin is exposed to carbon monoxide and whose levels can be easily monitored with a blood test, are a good indicator of whether carbon monoxide levels remain safe.

The unique liquid to the gas transformation of HBI-002 enables more targeted dosing since the amount needed can vary between individuals.

If approved for humans, it will help ensure dosing accuracy and the ability of patients eventually to easily and safely use the compound at home.



Source-Medindia